Quest Labs is a technology company.
Quest Labs has raised $120K across 1 funding round.
Quest Labs has raised $120K in total across 1 funding round.
Quest Diagnostics is the world's leading provider of diagnostic information services, delivering laboratory testing and diagnostic insights to empower individuals, physicians, and organizations to improve health outcomes.[1][2][4] The company serves one in three adult Americans and half of U.S. physicians and hospitals annually, leveraging one of the largest databases of de-identified clinical lab results to identify diseases, inspire healthy behaviors, and enhance healthcare management; it employs nearly 50,000 people committed to "The Quest Way," encompassing purpose, strategy, and culture.[1][2][4]
As a mature healthcare technology player rather than a startup, Quest focuses on advanced lab services, including gene-based and molecular testing, healthcare IT, data analytics, wellness, and direct-to-consumer testing via platforms like questhealth.com, where users can buy tests without a doctor visit and access results online.[4][5][7]
Quest Diagnostics, founded as a spin-off from Corning Inc. in the 1990s (exact year not specified in sources), has evolved into a Fortune 500 clinical laboratory operating in the U.S., Puerto Rico, Mexico, and Brazil.[8] A pivotal leadership shift occurred in 2013 when James Davis, an aeronautical engineer with prior experience at GE designing turbine blades and leading healthcare diagnostics like MRI, joined as an executive; he advanced to senior VP of operations in 2014 and became CEO and president in 2022.[3]
Davis drove the company's push into advanced automation, noting the lab industry's lag behind manufacturing upon arrival and spearheading fully automated facilities where specimens are scanned, placed in pucks, and routed to analyzers—marking early traction in operational transformation.[3]
Quest rides the wave of lab automation and AI in diagnostics, addressing healthcare's shift toward data-driven, efficient testing amid rising demand for personalized medicine and preventive care.[3] Timing aligns with post-pandemic emphasis on scalable testing infrastructure, where Quest's database and automation counter industry lags in tech adoption compared to manufacturing.[3]
Market forces like aging populations, chronic disease prevalence, and regulatory pushes for outcomes-based care favor its model; it influences the ecosystem by powering physician decisions, enabling wellness programs, and pioneering AI-enhanced labs that set standards for competitors.[1][2][3][4]
Quest Diagnostics will likely deepen AI and automation across its network, building on advanced facilities to boost efficiency and insights amid growing demand for molecular and gene-based testing.[3][7] Trends like AI-driven predictive diagnostics and expanded at-home services will shape its path, potentially amplifying influence through partnerships in healthcare IT and global expansion.[3][5][6]
This positions Quest to sustain its diagnostic dominance, evolving from lab giant to AI-powered health intelligence leader, directly advancing its mission of a healthier world one life at a time.[1][4]
Quest Labs has raised $120K in total across 1 funding round.
Quest Labs's investors include Afore Capital, Andreessen Horowitz, Norio Ventures, Picus Capital.
Quest Labs has raised $120K across 1 funding round. Most recently, it raised $120K Seed in April 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2023 | $120K Seed | Afore Capital, Andreessen Horowitz, Norio Ventures, Picus Capital |